Followers | 28 |
Posts | 4379 |
Boards Moderated | 1 |
Alias Born | 09/22/2006 |
![](https://investorshub.advfn.com/uicon/82750.png?cb=1713905033)
Wednesday, October 23, 2019 7:38:25 AM
Today 4:12 AM ET (Dow Jones)
--------------------------------------------------------------------
The following table shows the largest shareholders in REVANCE THERAPEUTICS INC COM (RVNC) for the quarter ended September 30, 2019, listed by holding size. The list represents up to 50 of the largest holders in the company.
--------------------------------------------------------------------
Note: Unless otherwise mentioned the reporting date is 09/30/2019
--------------------------------------------------------------------
Institution Shares Shares % Last Held Changed Held Report
Wellington Management Co. LLP 5,703,467 (40,667) 12.932 06/30
ArrowMark Colorado Holdings LL 4,310,996 901,779 9.775 06/30
Franklin Advisers Inc. 3,484,150 83,094 7.900 06/30
BlackRock Fund Advisors 3,240,557 204,854 7.348 06/30
The Vanguard Group Inc. 2,166,890 141,783 4.913 06/30
AllianceBernstein LP 2,043,800 2,671 4.634 06/30
Capital Research & Management 1,685,000 0 3.821 06/30
JPMorgan Investment Management 1,337,509 (1,141,586) 3.033 06/30
Renaissance Technologies LLC 1,330,973 428,900 3.018 06/30
BNY Mellon Investment Adviser 1,264,053 (13,971) 2.866 06/30
JPMorgan Asset Management (UK) 1,023,891 (113,031) 2.322 06/30
SSgA Funds Management Inc. 939,072 125,629 2.129 06/30
Rice Hall James & Associates 882,769 765,701 2.002 06/30
Mellon Investments Corp. 675,081 (34,891) 1.531 06/30
BAMCO Inc. 635,200 126,000 1.440 06/30
Geode Capital Management LLC 561,114 72,767 1.272 06/30
Northern Trust Investments In 505,445 6,511 1.146 06/30
DWS Investment GmbH 492,640 34,048 1.117 06/30
Sio Capital Management LLC 403,664 149,083 0.915 06/30
Dimensional Fund Advisors LP 390,328 16,424 0.885 06/30
Capital Research & Management 325,000 0 0.737 06/30
The Bank of New York Mellon Co 314,663 9,874 0.713 06/30
Charles Schwab Investment Mana 242,764 17,383 0.550 09/30
Jacobs Levy Equity Management 238,847 238,847 0.542 06/30
Candriam Belgium SA 237,000 0 0.537 06/30
Principal Global Investors LLC 223,565 109,297 0.507 06/30
Rhenman & Partners Asset Manag 173,917 (19,264) 0.394 09/30
BlackRock Investment Managemen 152,395 16,181 0.346 06/30
Citadel Advisors LLC 143,323 (63,128) 0.325 06/30
State of Wisconsin Investment 126,329 55,029 0.286 06/30
Teachers Advisors LLC 122,709 15,642 0.278 06/30
Columbia Management Investment 118,225 (17,677) 0.268 06/30
Point72 Asset Management LP 115,700 115,700 0.262 06/30
JPMorgan Chase Bank NA (Inves 113,503 (168,330) 0.257 06/30
Parametric Portfolio Associate 111,215 53,810 0.252 06/30
USAA Asset Management Co. 82,862 725 0.188 06/30
TIAA-CREF Investment Managemen 80,628 16,560 0.183 06/30
Shigeta Yasumitsu (Investment 80,100 80,100 0.182 06/30
Vanguard Fiduciary Trust Co. 80,054 4,661 0.182 06/30
Deka Investment GmbH 80,000 80,000 0.181 06/30
BlackRock Advisors LLC 74,674 (156,741) 0.169 06/30
Schweizerische Nationalbank (I 73,350 3,900 0.166 06/30
California State Teachers' Ret 67,799 8,542 0.154 06/30
Squarepoint OPS LLC 67,528 40,082 0.153 06/30
First Midwest Bank Trust Divis 67,141 (37,322) 0.152 09/30
Susquehanna Financial Group LL 65,661 65,661 0.149 06/30
RhumbLine Advisers LP 63,396 14,272 0.144 06/30
QS Investors LLC 61,725 (1,436) 0.140 06/30
Quinn Opportunity Partners LLC 52,672 (4,000) 0.119 06/30
The California Public Employee 49,100 (2,655) 0.111 06/30
13F data provided by: Factset Research Systems Inc.;
Please send questions to ownership@factset.com.
Copyright, Factset Research Systems, 2019. All Rights Reserved.
(END) Dow Jones Newswires
October 23, 2019 04:12 ET (08:12 GMT)
The more you know, the less you don't know.
Recent RVNC News
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/14/2024 08:05:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:33:08 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 08:08:10 PM
- Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update • Business Wire • 05/09/2024 08:06:00 PM
- Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia • Business Wire • 05/09/2024 08:05:00 PM
- Revance to Release First Quarter 2024 Financial Results on Thursday, May 9, 2024 • Business Wire • 05/02/2024 08:05:00 PM
- Revance to Present New DAXXIFY® Data at the American Academy of Neurology 2024 Annual Meeting • Business Wire • 04/12/2024 12:00:00 PM
- Revance Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 03/27/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:33:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2024 10:08:05 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/05/2024 10:00:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:34:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 10:33:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:44:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2024 09:33:28 PM
- Revance Announces Pricing of $100.0 Million Public Offering of Common Stock • Business Wire • 03/04/2024 02:25:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 03/04/2024 11:39:11 AM
- Revance Announces Proposed Public Offering of Common Stock • Business Wire • 03/04/2024 11:37:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/29/2024 09:36:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:07:18 PM
- Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update • Business Wire • 02/28/2024 09:05:00 PM
- Revance to Release Fourth Quarter and Full Year 2023 Financial Results on Wednesday February 28, 2024 • Business Wire • 02/21/2024 01:01:00 PM
- Revance to Participate in Upcoming Investor Conferences • Business Wire • 02/21/2024 01:00:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:45:13 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM